|

Meaning-Centered Pain Coping Skills Training for Cancer Pain

RECRUITINGN/ASponsored by Duke University
Actively Recruiting
PhaseN/A
SponsorDuke University
Started2023-02-09
Est. completion2026-05
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

This study is a randomized controlled trial of a psychosocial pain management intervention called, Meaning-Centered Pain Coping Skills Training (MCPC). Patients with advanced solid tumor cancer and pain interference (N=210) will be randomized to MCPC or a standard care control condition. Patient-reported outcomes will be assessed at baseline and 8- and 12-week follow-ups. The risk and safety issues in this trial are low and limited to those common to a psychosocial intervention (e.g., loss of confidentiality).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Stage IV solid tumor cancer diagnosis
* Eastern Cooperative Oncology Group (ECOG) performance status of 2 or lower
* At least one clinical pain severity rating \> 0 out of 10 in past month
* At least moderate pain interference (8-item Patient-Reported Outcomes Measurement Information System \[PROMIS\] Pain Interference T-score \>/= 55) in the past week at telephone screening
* Ability to speak and read in English
* Age \>/= 18 years.

Exclusion Criteria:

* Significant cognitive impairment as indicated in medical chart or during telephone screening
* Serious untreated mental illness
* Primary brain cancer diagnosis
* Previous engagement in Pain Coping Skills Training or Meaning-Centered Psychotherapy
* Enrollment in hospice at screening

Conditions3

Advanced Solid TumorCancerPain

Locations1 site

Duke Cancer Center
Durham, North Carolina, 27710
Joseph G Winger, PhD919-416-7506joseph.winger@duke.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.